
ViiV Healthcare continues to deliver long-acting injectable HIV innovation with late-breaking data and real-world ...
Cabotegravir for Pre-exposure prophylaxis (PrEP) PILLAR month 12 clinical results: zero HIV acquisition and high persistence with CAB LA for PrEP T. Khan Oral Abstract 196 12 March 2025 10:00 AM PT Performance of HIV RNA screening in the context of long- …